Fabry Disease Therapeutic Market Analysis 2018-2025: Merc & Co, AbbVie Inc, Shire, Protalix, Pfizer, Amicus Therapeutics, Green Cross Corp
Marketexpertz Experts an increase in the number of newly diagnosed cases of Fabry disease, and consequently in the number of treatable Fabry patients, as a result of increasing awareness of Fabry disease among physicians. ERT is now well established in the treatment of Fabry disease; however, there still remains concern about its efficacy, tissue penetrance, and intravenous administration. As a result, alternative approaches are being investigated to advance new treatments for Fabry disease, which focus on three main areas of...
View full press release